Replies to post #592806 on BB's Stock Haven

[eagleeye]

IMDS device detects blood flow towards a tumor. Cancer requires blood flow, so as I understand it from their website, the technology detects angiogenesis -or blodd vessel fromation--which is what is always present with cancer.

If there is NO blood flow or capillaries growing towards the lesion on a mammogram, them the lesion will turn out NOT to be cancerous.

Huge market. But no short cuts with the FDA. Knobias said that the last time they filed with the FDA in 2003, the stock went from .20 to 1.90 over three months.

Just watching IMDS for a repeat.

[eagleeye]

Technically speaking, IMDS needs to get over and STAY over .20 for me to load up. Just have 20,000 shares down here because I am not always near a computer--and if they have news--.20 and higher should be easy. Just want some of the cheap shares now. Definitely not a momentum play.

LOL

[eagleeye]

IMDS DID go up 900% three years ago when the filed with the FDA. 3 year chart. Now how long before they file again? And does the stock go up in anticipation of the filing timing?

No one will care until the stock, imo, gets over the .20 with good volume.